Cleveland County District Judge Thad Balkman signed the agreement calling for the funds to be used to help abate the state's opioid crisis.

Follow Israel Hayom on Facebook and Twitter

Under the deal, Teva admitted to no wrongdoing and agreed not to promote opioids in Oklahoma. The company also agreed to help law enforcement investigate cases of opioid drug diversion or other criminal activity.

"The resources and terms of the agreement will help abate the ongoing crisis the state is facing, help prevent doctors and Oklahomans from being misled by marketing materials and provides law enforcement with another investigative tool to help us shut down pill mills and illicit enterprises," Oklahoma Attorney-General Mike Hunter said in a statement.

A Teva spokeswoman didn't immediately respond to a request for comment on the settlement's approval.

Under the deal, outside attorneys hired by the state will receive nearly $13 million of the settlement money. The rest of the funds will be placed into a special account in the state treasury.

Balkman said the deal also does not release Teva from any separate claims that might be brought by individual cities or counties. At least nine Oklahoma cities have separately filed claims against similar drug manufacturers, including Teva.

The post Oklahoma judge signs state's $85M settlement with Israeli drugmaker appeared first on www.israelhayom.com.

Israeli-owned Teva Pharmaceuticals and Oklahoma Attorney General Mike Hunter both announced the settlement on Sunday in separate statements. Teva, its related affiliates, Johnson & Johnson and several of its subsidiaries were set to go to trial Tuesday in Norman, Oklahoma.

Hunter said the case against Johnson & Johnson will proceed on schedule.

He also said that the funds from the settlement with Teva will be used to fight the opioid crisis in Oklahoma.

Teva did not admit any wrongdoing under the settlement.

Earlier this year, Oklahoma settled with OxyContin-maker Purdue Pharma for $270 million.

The post Teva settles with Oklahoma for $85 million in opioid case appeared first on www.israelhayom.com.

According to the report, which was released on May 16 under the title, "Addressing Problematic Opiod Use in OECD Countries," data from 2014-2016 put Israel in 11th place out of 37 OECD countries for opioid use, a 13% increase from 2013, when Israel ranked 24th. However, Israel leads the pack when it comes to the rate of increase in opioid use – from 2011-2013 to 2014-2016 Israel experienced a 125% increase.

The report explains that "opioids are a type of narcotic medication that have become the basis of therapy for moderate to severe pain in many developed countries," and goes on to say that prescriptions of opioid analgesics have been steadily rising in OECD countries, including for "chronic, nonmalignant pain."

The report points to over-prescription of opioids as one of the main contributing factors in the growth of problematic opioid use.

In the 2014-2016 period, among the countries above the OECD average in availability of analgesic opioids, only four saw decreased use: the United States (-12.9%), Belgium (-7.3%), Denmark (-18.2%) and Australia (-10.9%).

The report revealed that some 87,000 Israelis use opioid analgesics on a daily basis.

Information on opioid-related deaths is apparently not collected in Israel, but in the 25 OECD countries in which such data is collected the average rate of opioid-related death has increased by 20% in recent years. In the United States, between 1999 and 2017, 399,230 people died from an opioid overdose.

The Health Ministry has reportedly established a committee to address the issue.

The post Report: Israel has the highest opioid use increase in the OECD appeared first on www.israelhayom.com.